ASTCNasdaqLaboratory Analytical InstrumentsUS GAAP · USD

ASTROTECH Corp

Astrotech Corp is a U.S.-based analytical instruments company commercializing mass spectrometry and gas chromatography technologies through a set of application-specific subsidiaries. Its products are designed for real-time detection of chemical compounds in security, industrial, environmental, and regulated testing environments. The company’s core platform includes the TRACER 1000, BreathTest-1000, AGLAB 1000, and Pro-Control 1000, along with related accessories and consumables. Astrotech’s strategy is to simplify complex laboratory-grade detection into rugged, portable systems that can be used on site rather than sent to off-site labs.

Operating profit (EBIT)-14.1m USD
+4.0 %y/y
Net income-14.4m USD
−4.2 %y/y
Free cash flow-14.3m USD
−4.0 %y/y

Fiscal year 2026 · change from previous year

Development 2021–2026

-15-10-505m USD2021: 0.33 m USD2021: EBIT -7.9 m USD20212022: 0.87 m USD2022: EBIT -8.6 m USD20222023: 0.75 m USD2023: EBIT -11 m USD20232024: 1.7 m USD2024: EBIT -13 m USD20242025: 1.0 m USD2025: EBIT -15 m USD20252026: EBIT -14 m USD2026-14
RevenueOperating profit (EBIT)

Business

Share of revenue
Security detection systems40 %

Portable mass-spectrometry-based devices used to detect explosives, narcotics, and related threats in security screening settings.

Industrial and process analytics20 %

Analytical instruments used for process control, quality assurance, and closed-loop testing in industrial environments.

Environmental and field testing15 %

Rugged on-site instruments and services used by environmental, remediation, and compliance customers.

Cannabis and hemp testing10 %

AgLAB products and related channel programs serving hemp and cannabis operators and labs.

Services and recurring support15 %

Maintenance, repairs, warranties, training, and consumables tied to installed instruments.

Products

Reported · share of revenue
76.6%12.4%11.0%FY2025100 %
  • Products76.6 %
  • Services12.4 %
  • Grant11.0 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

Astrotech sells to customers that need fast, on-site chemical identification rather than traditional off-site laboratory testing. Its security products are aimed at airports, cargo screening operators, law enforcement agencies, border and infrastructure security organizations, and other government users that need reliable detection with low false alarms. EN-SCAN is used by environmental consulting firms, government agencies, industrial facilities, and academic institutions that value portability and compliance support. Pro-Control targets food, petrochemical, chemical, and industrial companies near manufacturing clusters, while AgLAB is being pushed through direct and channel partners serving hemp and cannabis customers. The company also generates recurring revenue from consumables, service contracts, repairs, and training tied to installed systems.

Government and security agencies

Buy TRACER-based detection systems for airports, border checkpoints, law enforcement, military, and sensitive facilities because they need rapid, low-false-alarm screening.

Industrial and process customers

Buy Pro-Control and related analytical tools for process monitoring, quality control, and closed-loop manufacturing support.

Environmental and compliance users

Buy EN-SCAN devices and support services to perform portable field testing and reduce dependence on off-site labs.

Cannabis and hemp market customers

Buy AgLAB instruments through direct and distributor channels for analytical testing and process optimization.

Installed-base service customers

Buy consumables, maintenance, repairs, warranties, and training to keep deployed instruments operating and compliant.

Strategy

Astrotech is focused on commercializing its AMS Technology platform through wholly owned subsidiaries rather than a single broad product line. Near-term priorities are to improve uptime, expand detectable compound libraries, and convert field trials and proof-of-concept work into repeatable commercial deployments. The company is also trying to broaden distribution through channel partners, especially in AgLAB and in markets where existing distribution networks can accelerate adoption. Longer term, management wants to scale manufacturing capacity, expand R&D, and build a larger installed base that can generate recurring consumables and service revenue.

Commercialize application-specific instrumentsShort term

The company is still converting technology into repeatable product sales, so each subsidiary must prove market fit and adoption.

Expand channel sales and distributionShort term

Distributor relationships can shorten market access and reduce the burden of building a direct sales force in every niche market.

Increase installed base and recurring revenueMedium term

Consumables, maintenance, repairs, and training can improve revenue visibility and support customer retention after initial equipment sales.

Strengthen product performance and usabilityMedium term

Higher uptime, faster cleardown, ruggedization, and simpler interfaces are key differentiators versus competing analytical systems.

Geography

Q1/2026

Astrotech is headquartered in the United States but conducts business in multiple foreign countries and reports operations in both U.S. dollars and euros. The company states that its units are deployed in 34 locations across 16 countries, indicating a small but international installed base. Its commercial focus includes foreign airports and other overseas security markets, which exposes it to local regulatory, procurement, and currency conditions. The company also concentrates some direct-sales activity near its Austin, Texas headquarters, while using regional sales teams and distributors to reach broader U.S. and international markets.

United States64 %
Other countries (US filing)36 %

Share of the revenue the company reports by geography.

Risks

Astrotech remains a development-stage company with limited revenue and a history of losses, so execution risk is high. Its business depends on winning regulated and government customers, where sales cycles are long and procurement can be delayed by policy changes, budget timing, or approval requirements. The company also faces concentration risk because a small number of customers account for a large share of revenue, making results volatile if one customer reduces orders. In addition, international operations expose the company to currency, regulatory, and geopolitical risks, while the underlying analytical-instrument market also carries technology obsolescence, competition, supply-chain, and cybersecurity risks.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Need for additional capital1Regulatory and approval risk2Intellectual property disputes3Customer concentration4International operations and foreign currency5Cybersecurity and data protection6
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Need for additional capitalImpact: HighLikelihood: High

    The company expects ongoing R&D, manufacturing, and commercialization spending and may need equity funding to continue execution.

    Exposure: Dilution risk and funding uncertainty

  2. Regulatory and approval riskImpact: HighLikelihood: High

    Some products, especially BreathTest-1000, depend on lengthy and uncertain government or FDA-type approval processes.

    Exposure: Delayed commercialization or non-approval

  3. Intellectual property disputesImpact: HighLikelihood: High

    The company depends on proprietary detection technology and could face infringement claims or fail to secure protection.

    Exposure: Litigation cost or product restrictions

  4. Customer concentrationImpact: HighLikelihood: Medium

    Management disclosed that revenue is generated from a limited number of customers, so losing one account could materially reduce sales.

    Exposure: Revenue volatility and weaker operating leverage

  5. International operations and foreign currencyImpact: MediumLikelihood: Medium

    The company operates in multiple foreign countries and transacts in USD and EUR, creating translation and transaction exposure.

    Exposure: Margin and receivable volatility

  6. Cybersecurity and data protectionImpact: MediumLikelihood: Low

    Connected instruments and customer data create exposure to cyberattacks, downtime, and confidentiality breaches.

    Exposure: Operational disruption and reputational damage

Accounting

Judgemental items
Revenue recognition under ASC 606

Equipment, consumables, services, and grants may have different performance obligations and recognition timing.

Impact: Can shift revenue between periods and affect comparability

Collectability assessment

Management may defer revenue until collection is reasonably assured, especially with concentrated customers.

Impact: Can reduce reported revenue and increase contract judgment

Warranty and service provisions

Cost of revenue includes warranty expenses and repairs, which require estimates of future claims and support costs.

Impact: Affects gross margin and operating expense timing

Inventory valuation and obsolescence

Specialized instruments and components may become obsolete if demand or product design changes.

Impact: Potential write-downs can pressure gross margin

Long-lived asset recoverability

As a development-stage company, asset impairment risk rises if commercialization lags or cash flows disappoint.

Impact: Could trigger impairment charges

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

ASTROTECH Corp (ASTC) Revenue, Earnings & Financials 2025 – Clarifo